Drugs Made In America Acquisition Corp. (DMAAU) Cash from Operations (2025)
Drugs Made In America Acquisition's (DMAAU) quarterly Cash from Operations came in at 125180.0 in Q4 2025, down 123.11% on a QoQ basis from 56108.0 in Q3 2025.
Drugs Made In America Acquisition Corp. (DMAAU) Cash from Operations (2025) Analysis & Trends
Drugs Made In America Acquisition (DMAAU) has 1 years of Cash from Operations data on file, last reported at 125180.0 in Q4 2025.
- Quarterly Cash from Operations changed N/A year-over-year to 125180.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 539187.0 (changed N/A YoY) and the FY2025 annual result came in at 539187.0, down 213.0% from the prior year.
- Cash from Operations slipped to 125180.0 in Q4 2025, from 56108.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 56108.0 in Q3 2025 to a low of 251244.0 in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -125,180.00 |
| Dec 31, 2025 | -125,180.00 |
| Sep 30, 2025 | -56,108.00 |
| Sep 30, 2025 | -56,108.00 |
| Jun 30, 2025 | -106,655.00 |
| Jun 30, 2025 | -106,655.00 |
| Mar 31, 2025 | -251,244.00 |
| Mar 31, 2025 | -251,244.00 |